Publications by authors named "Margarita Ortega Cisneros"

Objective: To establish the prevalence of bronchiectasis, correlate the IgG IV or SC immunoglobulin dose and serum IgG levels with the total Bhalla score and the severity of bronchiectasis and associate serum IgG levels with the development of pulmonary infectious processes in patients with diagnosis of innate errors of immunity.

Methods: A descriptive, observational, cross-sectional study with patients over 18 years of age diagnosed with IBD. Clinical records and computed axial tomography were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • Adverse drug reactions (ADRs) can be classified into Type A (pharmacokinetics-related) and Type B (immune response-related), with Type B reactions being less well-defined and often categorized into immediate and delayed types.
  • This review aims to explore the immunological mechanisms behind delayed hypersensitivity reactions to medications, highlighting their complexities.
  • Findings discuss the classification, clinical signs, diagnosis, treatment plans, and overall prognosis of delayed hypersensitivity, emphasizing the need for prompt, tailored approaches by healthcare professionals.
View Article and Find Full Text PDF

Introduction: Aeroallergen exposure has an intra- and extra-domiciliary component and varies according to climatological zones. Mexico is a large country with a great variety of climates. A previous study (2009) evaluated skin prick test results (SPT) in different regions.

View Article and Find Full Text PDF

Inborn errors of immunity may present with autoimmunity and autoinflammation as hallmark clinical manifestations. We aimed to identify the potential monogenic causes of autoimmune disorders in 26 patients from a pediatric reference hospital in Mexico through whole-exome sequencing. We specifically selected patients with a family history of autoimmune diseases, early-onset symptoms, and difficult-to-control autoimmune disorders or autoimmunity associated with infection predisposition.

View Article and Find Full Text PDF

Introduction: Rituximab is an Anti-CD20 chimeric monoclonal antibody, being the treatment of lymphoproliferative diseases and rheumatological disorders; hypersensitivity reactions (HRS) are associated with infusion, cytokine release, type I (IgE/non-IgE), mixed, type III and IV. Desensitization seeks to induce tem- porary tolerance, decreasing the probability of clinical manifestations through gradual administration of the total dose of the drug, being target cells of the procedure, basophils, and mast cells, preventing their activation.

Case Report: The objective is to present a personalized desensitization protocol in a 36-year-old female patient with systemic lupus erythematosus (SLE) pre- viously treated with rituximab in 2019, 4 doses, presenting during the fourth administration, after 10 minutes, dyspnea, feeling foreign body in the pharynx, chest pain, angioedema, and neurological alteration.

View Article and Find Full Text PDF

Background: Any substance used as a treatment for any disease can produce harmful or unpleasant events called adverse drug reactions (ADRs). They are due to inherent biological effects of the drug and are caused by immunological and non-immunological mechanisms.

Objectives: To describe the immunological mechanisms of hypersensitivity reactions (HSR) to drugs, their epidemiology, risk factors, classification, clinical manifestations, diagnosis, treatment, and prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • Hereditary actin-related protein 2/3 complex subunit 1B deficiency leads to various health issues like recurrent infections, asthma, eczema, and bleeding, as seen in six patients from four Mexican families studied.
  • The patients exhibited a mix of symptoms, including high levels of certain immunoglobulins and platelet abnormalities, with genetic testing revealing notable variants in some and identifying similar cases in other reports.
  • The study highlights the diverse clinical manifestations of this deficiency, contributing new insights such as keloid scars and a potential genetic link between families due to a novel deletion in a specific gene region.
View Article and Find Full Text PDF

Betalactams are the most widely used antimicrobials for their safety and efficacy. These include the penicillins, cephalosporins, carbapenems, and monobactams. Penicillin allergy ranks first in relation to drug allergy.

View Article and Find Full Text PDF

Objective: To estimate the frequency of chronic urticaria in patients who attended an allergy service in a tertiary care hospital; in addition, the main clinical characteristics are described.

Methods: In a period of 7 months, a total of 96 patients who were over 18 years of age were analyzed; they had been diagnosed with chronic spontaneous urticaria and chronic inducible urticaria.

Results: The frequency of chronic urticaria was of 1.

View Article and Find Full Text PDF

Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in these regions are adapted to local practice.

View Article and Find Full Text PDF

Introduction: Common variable immunodeficiency (CVID) is the main symptomatic primary immunodeficiency and is associated with complex immune disorders. Gut microbiota interacts closely with the immune system, and intestinal dysbiosis is related to multiple diseases.

Objective: To describe for the first time the composition of gut microbiota in Mexican patients with CVID.

View Article and Find Full Text PDF

Introduction: Common variable immunodeficiency (CVID) is the main symptomatic primary immunodeficiency and is associated with complex immune disorders. Gut microbiota interacts closely with the immune system, and intestinal dysbiosis is related to multiple diseases.

Objective: To describe for the first time the composition of gut microbiota in Mexican patients with CVID.

View Article and Find Full Text PDF

Background: In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school. In addition, both types of extracts (European and American) are commercially available in Mexico. Moreover, for an adequate AIT/VIT a timely diagnosis is crucial.

View Article and Find Full Text PDF